International
The Morning Science

What science found today

‹
 

Research

Blocking receptor signals can help treat fibrosis

Medical Xpress ·

Blocking receptor signals can help treat fibrosis

The Brief

  • An investigator-initiated trial showed that inhibiting the cytokines IL-4 and IL-13 can prevent fibrosis in localized scleroderma, a skin disease.
  • The researchers suggest the findings could pave the way for preventing and treating other fibrotic conditions.
  • The source summary is brief and does not give trial size, dosing, or detailed results.

Why it matters

The result points to IL-4 and IL-13 signalling as a possible target for stopping fibrosis, a process relevant to many diseases beyond localized scleroderma.

Who’s affected

  • clinicians and researchers working on fibrotic or autoimmune skin diseases
  • researchers studying cytokine signalling and tissue fibrosis

In an investigator-initiated trial, researchers have shown that inhibiting the cytokines IL-4 and IL-13 can prevent fibrosis in the skin disease localized scleroderma. These findings could pave the way for the prevention and treatment of other fibrotic conditions. The study…

Timeline

  1. Medical Xpress reported the investigator-initiated trial results on blocking IL-4 and IL-13 in localized scleroderma

  2. Medical Xpress - latest medical and health news stories

    Blocking receptor signals can help treat fibrosis

How do you feel about this?

0 Comments

    Blocking receptor signals can help treat fibrosis – The Morning Science